Citation 8364

MATSUDA,H: NINOMIYA,K: SHIMODA,H: YOSHIKAWA,M:. (2002). HEPATOPROTECTIVE PRINCIPLE FROM THE FLOWERS OF TILIA ARGENTEA (LINDEN): STRUCTURE REQUIREMENTS OF TILIROSIDE AND MECHANISMS OF ACTION.. 10(3)

Citation Details

Title	HEPATOPROTECTIVE PRINCIPLE FROM THE FLOWERS OF TILIA ARGENTEA (LINDEN): STRUCTURE REQUIREMENTS OF TILIROSIDE AND MECHANISMS OF ACTION.
Authors	MATSUDA,H: NINOMIYA,K: SHIMODA,H: YOSHIKAWA,M:
Year	2002
Volume	10
Issue	3

Summary

Year: 2002

Journal: Unknown

Organisms and Their Experiments (2)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIHEPATOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	ACTIVE
2	ANTIHEPATOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	KAEMPFEROL	ACTIVE
3	CELL PROLIFERATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	ACTIVE
4	ANTIHEPATOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	COUMARIC ACID,PARA:	INACTIVE
5	ANTIHEPATOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	COUMARIC ACID,PARA:	INACTIVE
6	CELL PROLIFERATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	COUMARIC ACID,PARA:	ACTIVE

Tilia argentea (TILIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIHEPATOTOXIC ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
2	ANTIHEPATOTOXIC ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
3	ANTIHEPATOTOXIC ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
4	ANTIHEPATOTOXIC ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITRO	None	INACTIVE
5	ANTIHEPATOTOXIC ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
6	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	TILIROSIDE	None
7	ANTIHEPATOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TILIROSIDE	ACTIVE
8	ANTIHEPATOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	TILIROSIDE	ACTIVE
9	CELL PROLIFERATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	TILIROSIDE	ACTIVE
10	TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	TILIROSIDE	ACTIVE
11	TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TILIROSIDE	ACTIVE
12	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	ASTRAGALIN	None
13	ANTIHEPATOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ASTRAGALIN	ACTIVE
14	ANTIHEPATOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVO	ASTRAGALIN	ACTIVE
15	CELL PROLIFERATION STIMULATION	PHARMACOLOGY OF COMPOUND - IN VITRO	ASTRAGALIN	ACTIVE
16	TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VIVO	ASTRAGALIN	ACTIVE
17	TUMOR NECROSING FACTOR-ALPHA RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ASTRAGALIN	ACTIVE
18	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	QUERCITRIN,ISO:	None
19	ANTIHEPATOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCITRIN,ISO:	ACTIVE
20	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	AFZELIN	None
21	ANTIHEPATOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	AFZELIN	ACTIVE
22	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	QUERCITRIN	None
23	ANTIHEPATOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCITRIN	ACTIVE
24	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	KAEMPFERITRIN	None
25	ANTIHEPATOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFERITRIN	ACTIVE